Yingchuan Que
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yingchuan Que has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Gang Chen
Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, People's Republic of China
4 shared publications Dazhi Zhou
Department of Chemistry
2 shared publicationsMadiha Butt
State Key Laboratory of Synergistic Chem-Bio Synthesis, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, China
2 shared publicationsRuoqian Xie
State Key Laboratory of Synergistic Chem-Bio Synthesis, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering
2 shared publicationsYangyan Li
State Key Laboratory of Synergistic Chem-Bio Synthesis, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, China
2 shared publicationsYujie Jiang
State Key Laboratory of Synergistic Chem-Bio Synthesis, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Chemistry and Chemical Engineering
2 shared publications
Latest Publications
- 22 June 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (25) , 26629-26648
Late-Stage Carboranylation of Nucleos(t)ides Enabled by Minisci and Pd-Catalyzed B–N Cross-Coupling Reactions: Toward the Synthesis of Carboranyl-Modified Oligonucleotides
Carboranyl-modified nucleosides are promising boron-10 (10B) delivery agents for boron neutron capture therapy (BNCT), yet methods for directly forming B-C/B-N bonds at unprotected nucleosides are scarce. We report herein two operationally simple, orthogonal strategies for the late-stage installation of carboranyl units at heteroaromatic C(sp2) centers and exocyclic amino groups of native nucleosides, nucleotides, and analogues. The first method uses a visible-light-mediated Minisci-type radical reaction, where 9-meta-carboranyltrifluoroborate serves as a nucleophilic B(9)-vertex radical precursor to selectively forge C(sp2)-B bonds at the C8-position of guanine, C2-position of adenine, and C5-position of uracil. Theoretical calculations revealed that the selectivity for adenosine and uridine is substrate-dependent: in adenosine, C2-selectivity arises from steric repulsion that disfavors C8-addition, whereas in uridine, C5-selectivity is dictated by stabilizing interactions. The second strategy employs Pd-catalyzed Buchwald-Hartwig-type amination to form B-N bonds at the N6-position of adenosine, the N2-position of guanosine, and the N4-position of cytidine. Furthermore, carboranyl groups were successfully incorporated into DNA oligonucleotides at various positions via solid-phase synthesis. To assess their suitability for BNCT applications, 10B-enriched carboranyl-modified oligonucleotides, carboranyl-modified DNA aptamers (Sgc8c) targeting protein tyrosine kinase 7 (PTK7), along with 10B-enriched carboranyl-modified aptamers, were prepared. Cellular uptake studies showed that the aptamer-carborane conjugates effectively recognize and internalize into PTK7-overexpressing HCT116 cells, thereby providing a basis for future exploration of BNCT applications. These methods expand the chemical space of boron-rich nucleos(t)ides and represent a step toward the development of next-generation BNCT agents.
- 22 June 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (25) , 26629-26648
Late-Stage Carboranylation of Nucleos(t)ides Enabled by Minisci and Pd-Catalyzed B–N Cross-Coupling Reactions: Toward the Synthesis of Carboranyl-Modified Oligonucleotides
Carboranyl-modified nucleosides are promising boron-10 (10B) delivery agents for boron neutron capture therapy (BNCT), yet methods for directly forming B-C/B-N bonds at unprotected nucleosides are scarce. We report herein two operationally simple, orthogonal strategies for the late-stage installation of carboranyl units at heteroaromatic C(sp2) centers and exocyclic amino groups of native nucleosides, nucleotides, and analogues. The first method uses a visible-light-mediated Minisci-type radical reaction, where 9-meta-carboranyltrifluoroborate serves as a nucleophilic B(9)-vertex radical precursor to selectively forge C(sp2)-B bonds at the C8-position of guanine, C2-position of adenine, and C5-position of uracil. Theoretical calculations revealed that the selectivity for adenosine and uridine is substrate-dependent: in adenosine, C2-selectivity arises from steric repulsion that disfavors C8-addition, whereas in uridine, C5-selectivity is dictated by stabilizing interactions. The second strategy employs Pd-catalyzed Buchwald-Hartwig-type amination to form B-N bonds at the N6-position of adenosine, the N2-position of guanosine, and the N4-position of cytidine. Furthermore, carboranyl groups were successfully incorporated into DNA oligonucleotides at various positions via solid-phase synthesis. To assess their suitability for BNCT applications, 10B-enriched carboranyl-modified oligonucleotides, carboranyl-modified DNA aptamers (Sgc8c) targeting protein tyrosine kinase 7 (PTK7), along with 10B-enriched carboranyl-modified aptamers, were prepared. Cellular uptake studies showed that the aptamer-carborane conjugates effectively recognize and internalize into PTK7-overexpressing HCT116 cells, thereby providing a basis for future exploration of BNCT applications. These methods expand the chemical space of boron-rich nucleos(t)ides and represent a step toward the development of next-generation BNCT agents.
- Open Access
- 21 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Late-stage adenine N6-alkylation of nucleos(t)ides and oligonucleotides via photoredox and copper co-catalytic decarboxylative C(sp3)–N coupling
Nucleosi(ti)des and nucleic acids with N6 modified adenosine play an important role in the areas of disease diagnosis and treatment, biological chemistry, as well as nanotechnology. The conventional way to achieve N6 alkylation includes nucleophilic aromatic substitution reaction from N6 activated adenosine and direct reductive amination from adenosine. However, nucleophilic aromatic substitution reaction needs pre-functionalization of adenosine and reductive amination has limited alkyl substrate groups, especially not compatible with the secondary and tertiary alkyl groups. Herein, we develop a practical alkylation at the N6-position of adenines in adenosine and its analogues as well as late-stage functionalization of nucleotides/oligonucleotides through photoredox and copper co-catalyzed decarboxylative C(sp3)–N cross-coupling reaction. This method features simplicity and directness with various free radical precursors which is promising for medicinal and biological applications.
- 21 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessLate-stage adenine N6-alkylation of nucleos(t)ides and oligonucleotides via photoredox and copper co-catalytic decarboxylative C(sp3)–N coupling
Nucleosi(ti)des and nucleic acids with N6 modified adenosine play an important role in the areas of disease diagnosis and treatment, biological chemistry, as well as nanotechnology. The conventional way to achieve N6 alkylation includes nucleophilic aromatic substitution reaction from N6 activated adenosine and direct reductive amination from adenosine. However, nucleophilic aromatic substitution reaction needs pre-functionalization of adenosine and reductive amination has limited alkyl substrate groups, especially not compatible with the secondary and tertiary alkyl groups. Herein, we develop a practical alkylation at the N6-position of adenines in adenosine and its analogues as well as late-stage functionalization of nucleotides/oligonucleotides through photoredox and copper co-catalyzed decarboxylative C(sp3)–N cross-coupling reaction. This method features simplicity and directness with various free radical precursors which is promising for medicinal and biological applications.
- Open Access
- 30 November 2025
- Published by Elsevier in Plant Physiology and Biochemistry
- Vol. 230, 110841
Enhancement of root growth under salt stress through the application of β-cyclocitral derivatives DQC-8 in Oryza sativa L
- 30 November 2025
- Published by Elsevier in Plant Physiology and Biochemistry
- Vol. 230, 110841
Open AccessEnhancement of root growth under salt stress through the application of β-cyclocitral derivatives DQC-8 in Oryza sativa L
- 25 July 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (31) , 21428-21441
Regioselective Homolytic C2–H Borylation of Unprotected Adenosine and Adenine Derivatives via Minisci Reaction
A Minisci-type borylation of unprotected adenosine, adenine nucleotide, and adenosine analogues was successfully achieved through photocatalysis or thermal activation. Despite the challenges posed by the presence of two potential reactive sites (C2 and C8) in the purine motif, the unique nucleophilic amine-ligated boryl radicals effortlessly achieved excellent C2 site selectivity and simultaneously avoided the formation of multifunctionalized products. This protocol proved effective for the late-stage borylation of some important biomolecules as well as a few antiviral and antitumor drug molecules, such as AMP, cAMP, Vidarabine, Cordycepin, Tenofovir, Adefovir, GS-441524, etc. Theoretical calculations shed light on the site selectivity, revealing that the free energy barriers for the C2-Minisci addition are further lowered through the chelation of additive Mg2+ to N3 and furyl oxygen. This phenomenon has been confirmed by an IGMH analysis. Preliminary antitumor evaluation, derivation of the C2-borylated adenosine to other analogues with high-value functionalities, along with the CuAAC click reactions, suggest the potential application of this methodology in drug molecular optimization studies and chemical biology.
- 25 July 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (31) , 21428-21441
Regioselective Homolytic C2–H Borylation of Unprotected Adenosine and Adenine Derivatives via Minisci Reaction
A Minisci-type borylation of unprotected adenosine, adenine nucleotide, and adenosine analogues was successfully achieved through photocatalysis or thermal activation. Despite the challenges posed by the presence of two potential reactive sites (C2 and C8) in the purine motif, the unique nucleophilic amine-ligated boryl radicals effortlessly achieved excellent C2 site selectivity and simultaneously avoided the formation of multifunctionalized products. This protocol proved effective for the late-stage borylation of some important biomolecules as well as a few antiviral and antitumor drug molecules, such as AMP, cAMP, Vidarabine, Cordycepin, Tenofovir, Adefovir, GS-441524, etc. Theoretical calculations shed light on the site selectivity, revealing that the free energy barriers for the C2-Minisci addition are further lowered through the chelation of additive Mg2+ to N3 and furyl oxygen. This phenomenon has been confirmed by an IGMH analysis. Preliminary antitumor evaluation, derivation of the C2-borylated adenosine to other analogues with high-value functionalities, along with the CuAAC click reactions, suggest the potential application of this methodology in drug molecular optimization studies and chemical biology.